Cargando…
Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases
Repurposing is an increasingly attractive method within the field of drug development for its efficiency at identifying new therapeutic opportunities among approved drugs at greatly reduced cost and time of more traditional methods. Repurposing has generated significant interest in the realm of rare...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355705/ https://www.ncbi.nlm.nih.gov/pubmed/34394194 http://dx.doi.org/10.3389/fgene.2021.707836 |
_version_ | 1783736814269366272 |
---|---|
author | Challa, Anup P. Zaleski, Nicole M. Jerome, Rebecca N. Lavieri, Robert R. Shirey-Rice, Jana K. Barnado, April Lindsell, Christopher J. Aronoff, David M. Crofford, Leslie J. Harris, Raymond C. Alp Ikizler, T. Mayer, Ingrid A. Holroyd, Kenneth J. Pulley, Jill M. |
author_facet | Challa, Anup P. Zaleski, Nicole M. Jerome, Rebecca N. Lavieri, Robert R. Shirey-Rice, Jana K. Barnado, April Lindsell, Christopher J. Aronoff, David M. Crofford, Leslie J. Harris, Raymond C. Alp Ikizler, T. Mayer, Ingrid A. Holroyd, Kenneth J. Pulley, Jill M. |
author_sort | Challa, Anup P. |
collection | PubMed |
description | Repurposing is an increasingly attractive method within the field of drug development for its efficiency at identifying new therapeutic opportunities among approved drugs at greatly reduced cost and time of more traditional methods. Repurposing has generated significant interest in the realm of rare disease treatment as an innovative strategy for finding ways to manage these complex conditions. The selection of which agents should be tested in which conditions is currently informed by both human and machine discovery, yet the appropriate balance between these approaches, including the role of artificial intelligence (AI), remains a significant topic of discussion in drug discovery for rare diseases and other conditions. Our drug repurposing team at Vanderbilt University Medical Center synergizes machine learning techniques like phenome-wide association study—a powerful regression method for generating hypotheses about new indications for an approved drug—with the knowledge and creativity of scientific, legal, and clinical domain experts. While our computational approaches generate drug repurposing hits with a high probability of success in a clinical trial, human knowledge remains essential for the hypothesis creation, interpretation, “go-no go” decisions with which machines continue to struggle. Here, we reflect on our experience synergizing AI and human knowledge toward realizable patient outcomes, providing case studies from our portfolio that inform how we balance human knowledge and machine intelligence for drug repurposing in rare disease. |
format | Online Article Text |
id | pubmed-8355705 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83557052021-08-12 Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases Challa, Anup P. Zaleski, Nicole M. Jerome, Rebecca N. Lavieri, Robert R. Shirey-Rice, Jana K. Barnado, April Lindsell, Christopher J. Aronoff, David M. Crofford, Leslie J. Harris, Raymond C. Alp Ikizler, T. Mayer, Ingrid A. Holroyd, Kenneth J. Pulley, Jill M. Front Genet Genetics Repurposing is an increasingly attractive method within the field of drug development for its efficiency at identifying new therapeutic opportunities among approved drugs at greatly reduced cost and time of more traditional methods. Repurposing has generated significant interest in the realm of rare disease treatment as an innovative strategy for finding ways to manage these complex conditions. The selection of which agents should be tested in which conditions is currently informed by both human and machine discovery, yet the appropriate balance between these approaches, including the role of artificial intelligence (AI), remains a significant topic of discussion in drug discovery for rare diseases and other conditions. Our drug repurposing team at Vanderbilt University Medical Center synergizes machine learning techniques like phenome-wide association study—a powerful regression method for generating hypotheses about new indications for an approved drug—with the knowledge and creativity of scientific, legal, and clinical domain experts. While our computational approaches generate drug repurposing hits with a high probability of success in a clinical trial, human knowledge remains essential for the hypothesis creation, interpretation, “go-no go” decisions with which machines continue to struggle. Here, we reflect on our experience synergizing AI and human knowledge toward realizable patient outcomes, providing case studies from our portfolio that inform how we balance human knowledge and machine intelligence for drug repurposing in rare disease. Frontiers Media S.A. 2021-07-28 /pmc/articles/PMC8355705/ /pubmed/34394194 http://dx.doi.org/10.3389/fgene.2021.707836 Text en Copyright © 2021 Challa, Zaleski, Jerome, Lavieri, Shirey-Rice, Barnado, Lindsell, Aronoff, Crofford, Harris, Alp Ikizler, Mayer, Holroyd and Pulley. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Challa, Anup P. Zaleski, Nicole M. Jerome, Rebecca N. Lavieri, Robert R. Shirey-Rice, Jana K. Barnado, April Lindsell, Christopher J. Aronoff, David M. Crofford, Leslie J. Harris, Raymond C. Alp Ikizler, T. Mayer, Ingrid A. Holroyd, Kenneth J. Pulley, Jill M. Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases |
title | Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases |
title_full | Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases |
title_fullStr | Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases |
title_full_unstemmed | Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases |
title_short | Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases |
title_sort | human and machine intelligence together drive drug repurposing in rare diseases |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355705/ https://www.ncbi.nlm.nih.gov/pubmed/34394194 http://dx.doi.org/10.3389/fgene.2021.707836 |
work_keys_str_mv | AT challaanupp humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases AT zaleskinicolem humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases AT jeromerebeccan humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases AT lavierirobertr humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases AT shireyricejanak humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases AT barnadoapril humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases AT lindsellchristopherj humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases AT aronoffdavidm humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases AT croffordlesliej humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases AT harrisraymondc humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases AT alpikizlert humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases AT mayeringrida humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases AT holroydkennethj humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases AT pulleyjillm humanandmachineintelligencetogetherdrivedrugrepurposinginrarediseases |